A detailed history of Keybank National Association transactions in Neogenomics Inc stock. As of the latest transaction made, Keybank National Association holds 18,895 shares of NEO stock, worth $290,227. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,895
Previous 17,444 8.32%
Holding current value
$290,227
Previous $241,000 15.35%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$13.4 - $17.73 $19,443 - $25,726
1,451 Added 8.32%
18,895 $278,000
Q2 2024

Jul 31, 2024

BUY
$13.01 - $15.77 $32,056 - $38,857
2,464 Added 16.45%
17,444 $241,000
Q1 2024

May 14, 2024

BUY
$14.06 - $16.79 $210,618 - $251,514
14,980 New
14,980 $235,000
Q4 2021

Feb 07, 2022

SELL
$30.49 - $48.49 $158,517 - $252,099
-5,199 Closed
0 $0
Q3 2021

Nov 08, 2021

SELL
$41.66 - $52.52 $958 - $1,207
-23 Reduced 0.44%
5,199 $251,000
Q2 2021

Aug 12, 2021

SELL
$36.62 - $51.69 $155,012 - $218,803
-4,233 Reduced 44.77%
5,222 $236,000
Q1 2021

May 07, 2021

SELL
$41.56 - $59.88 $28,011 - $40,359
-674 Reduced 6.65%
9,455 $456,000
Q4 2020

Feb 09, 2021

SELL
$36.08 - $56.47 $9,128 - $14,286
-253 Reduced 2.44%
10,129 $545,000
Q3 2020

Oct 29, 2020

BUY
$33.26 - $40.48 $10,044 - $12,224
302 Added 3.0%
10,382 $383,000
Q2 2020

Aug 10, 2020

BUY
$24.21 - $31.02 $3,244 - $4,156
134 Added 1.35%
10,080 $312,000
Q1 2020

May 13, 2020

BUY
$20.5 - $34.53 $8,835 - $14,882
431 Added 4.53%
9,946 $275,000
Q4 2019

Feb 05, 2020

BUY
$18.96 - $29.84 $180,404 - $283,927
9,515 New
9,515 $278,000
Q3 2019

Nov 04, 2019

SELL
$19.12 - $26.24 $189,632 - $260,248
-9,918 Closed
0 $0
Q2 2019

Aug 01, 2019

BUY
$19.57 - $24.1 $194,095 - $239,023
9,918 New
9,918 $218,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.93B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.